These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 911603)

  • 1. Carbamazepine and carbamazepine-10, 11-epoxide concentrations in human brain.
    Morselli PL; Baruzzi A; Gerna M; Bossi L; Porta M
    Br J Clin Pharmacol; 1977 Oct; 4(5):535-40. PubMed ID: 911603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.
    Friis ML; Christiansen J; Hvidberg EF
    Eur J Clin Pharmacol; 1978 Nov; 14(1):47-51. PubMed ID: 729606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine, carbamazepine-10,11-epoxide and phenytoin concentrations in brain tissue of epileptic children.
    Friis ML; Christiansen J
    Acta Neurol Scand; 1978 Aug; 58(2):104-8. PubMed ID: 707037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
    Rane A; Höjer B; Wilson JT
    Clin Pharmacol Ther; 1976 Mar; 19(3):276-83. PubMed ID: 1261166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.
    MacKichan JJ; Duffner PK; Cohen ME
    Br J Clin Pharmacol; 1981 Jul; 12(1):31-7. PubMed ID: 7248139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
    Furlanut M; Montanari G; Bonin P; Casara GL
    J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered ratio of carbamazepine-10,11-epoxide/carbamazepine in plasma of children: evidence of anticonvulsant drug interaction.
    Schoeman JF; Elyas AA; Brett EM; Lascelles PT
    Dev Med Child Neurol; 1984 Dec; 26(6):749-55. PubMed ID: 6440824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
    Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
    Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous plasma carbamazepine and carbamazepine-epoxide concentrations in pharmacokinetic and bioavailability studies.
    Hooper WD; King AR; Patterson M; Dickinson RG; Eadie MJ
    Ther Drug Monit; 1985; 7(1):36-40. PubMed ID: 3992620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide.
    Tomson T; Tybring G; Bertilsson L
    Clin Pharmacol Ther; 1983 Jan; 33(1):58-65. PubMed ID: 6848300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery.
    Gidal BE; Spencer NW; Maly MM; Pitterle ME
    Epilepsia; 1996 Apr; 37(4):381-5. PubMed ID: 8603645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics: time-dependent changes--autoinduction of carbamazepine epoxidation.
    Bertilsson L; Tomson T; Tybring G
    J Clin Pharmacol; 1986; 26(6):459-62. PubMed ID: 3734137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of metabolic parameters of carbamazepine in the therapeutic monitoring of Tunisian patients with epilepsy.
    Chbili C; Hassine A; Ben Amor S; Nouira M; Ben Ammou S; Saguem S
    Rev Neurol (Paris); 2016; 172(4-5):313-7. PubMed ID: 27062293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-drug therapy with carbamazepine in patients with epilepsy: serum levels and clinical effect.
    Strandjord RE; Johannessen SI
    Epilepsia; 1980 Dec; 21(6):655-52. PubMed ID: 6777155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamazepine 10,11-epoxide in children.
    Rylance GW; Edwards C; Gard PR
    Br J Clin Pharmacol; 1984 Dec; 18(6):935-9. PubMed ID: 6529533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.
    Nakajima Y; Saito Y; Shiseki K; Fukushima-Uesaka H; Hasegawa R; Ozawa S; Sugai K; Katoh M; Saitoh O; Ohnuma T; Kawai M; Ohtsuki T; Suzuki C; Minami N; Kimura H; Goto Y; Kamatani N; Kaniwa N; Sawada J
    Eur J Clin Pharmacol; 2005 Mar; 61(1):25-34. PubMed ID: 15692831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early stage autoinduction of carbamazepine metabolism in humans.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Eur J Clin Pharmacol; 1994; 47(4):355-60. PubMed ID: 7875188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of carbamazepine and its active metabolite, carbamazepine-10,11-epoxide, in human plasma using high-performance liquid chromatography.
    Oh Ek; Ban E; Woo JS; Kim CK
    Anal Bioanal Chem; 2006 Nov; 386(6):1931-6. PubMed ID: 17019579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from Epoxide Metabolites of Carbamazepine in Patients.
    Yip VLM; Meng X; Maggs JL; Jenkins RE; Marlot PT; Marson AG; Park BK; Pirmohamed M
    Chem Res Toxicol; 2017 Jul; 30(7):1419-1435. PubMed ID: 28562019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.